Treatment with a platelet‐activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock-Reference-Cited by-同舟云学术

Treatment with a platelet‐activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock

Published:2019-12-10 Issue:3 Volume:50 Page:383-390
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Tacquard Charles¹²^ORCID,Oulehri Walid¹³,Collange Olivier¹³,Garvey Lene H.⁴⁵,Nicoll Susan⁶,Tuzin Nicolas²,Geny Bernard³,Mertes Paul M.¹³

Affiliation:

1. Department of anesthesia and intensive care Hôpitaux Universitaires de Strasbourg Nouvel Hôpital Civil Strasbourg France

2. Groupe Méthode en Recherche Clinique Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil Strasbourg France

3. EA 3072, Fédération de Médecine Translationnelle, Faculté de Médecine Université de Strasbourg Strasbourg France

4. Danish Anaesthesia Allergy Centre, Allergy Clinic, Department of Dermatology and Allergy Copenhagen University Hospital Gentofte Denmark

5. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

6. Department of Anaesthesia Christchurch Hospital Christchurch New Zealand

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13540

Reference34 articles.

1. The epidemiology of anaphylaxis in Europe: a systematic review

2. Epidemiology of perioperative anaphylaxis

3. Survival from perioperative anaphylaxis in Western Australia 2000–2009

4. Anaphylaxis During the Perioperative Period

5. The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan;Mitsuhata H;Masui,1992

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Refractory Anaphylaxis: An Overview of Current Guidelines;Clinical & Experimental Allergy;2024-06-12

2. Protective role of protease-activated receptor-2 in anaphylaxis model mice;PLOS ONE;2024-04-18

3. NButGT Reinforces the Beneficial Effects of Epinephrine on Cardiac Mitochondrial Respiration, Lactatemia and Cardiac Output in Experimental Anaphylactic Shock;International Journal of Molecular Sciences;2024-03-14

4. Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps;Clinical & Experimental Allergy;2024-01

5. Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents;ACS Omega;2023-12-19